JP2021513984A5 - - Google Patents

Info

Publication number
JP2021513984A5
JP2021513984A5 JP2020543611A JP2020543611A JP2021513984A5 JP 2021513984 A5 JP2021513984 A5 JP 2021513984A5 JP 2020543611 A JP2020543611 A JP 2020543611A JP 2020543611 A JP2020543611 A JP 2020543611A JP 2021513984 A5 JP2021513984 A5 JP 2021513984A5
Authority
JP
Japan
Prior art keywords
alkyl
pharmaceutically acceptable
acceptable salt
compound according
group
Prior art date
Application number
JP2020543611A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021513984A (ja
JP7291711B2 (ja
JPWO2019158572A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/053525 external-priority patent/WO2019158572A1/en
Publication of JP2021513984A publication Critical patent/JP2021513984A/ja
Publication of JPWO2019158572A5 publication Critical patent/JPWO2019158572A5/ja
Publication of JP2021513984A5 publication Critical patent/JP2021513984A5/ja
Application granted granted Critical
Publication of JP7291711B2 publication Critical patent/JP7291711B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020543611A 2018-02-15 2019-02-13 Trpc6阻害剤 Active JP7291711B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862630907P 2018-02-15 2018-02-15
US62/630,907 2018-02-15
PCT/EP2019/053525 WO2019158572A1 (en) 2018-02-15 2019-02-13 Inhibitors of trpc6

Publications (4)

Publication Number Publication Date
JP2021513984A JP2021513984A (ja) 2021-06-03
JPWO2019158572A5 JPWO2019158572A5 (https=) 2022-02-22
JP2021513984A5 true JP2021513984A5 (https=) 2022-02-22
JP7291711B2 JP7291711B2 (ja) 2023-06-15

Family

ID=65496750

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020543611A Active JP7291711B2 (ja) 2018-02-15 2019-02-13 Trpc6阻害剤

Country Status (5)

Country Link
US (1) US11485740B2 (https=)
EP (1) EP3752499B1 (https=)
JP (1) JP7291711B2 (https=)
CN (1) CN111770918B (https=)
WO (1) WO2019158572A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10202011632RA (en) * 2017-10-27 2021-01-28 Boehringer Ingelheim Int Pyridine carbonyl derivatives and therapeutic uses thereof as trpc6 inhibitors
WO2019241131A1 (en) 2018-06-11 2019-12-19 Pipeline Therapeutics, Inc. Muscarinic acetylcholine m1 receptor antagonists
US12054487B2 (en) 2018-09-04 2024-08-06 Contineum Therapeutics, Inc. Muscarinic acetylcholine M1 receptor antagonists
IL326597A (en) * 2019-10-07 2026-04-01 Contineum Therapeutics Inc Muscarinic M1 acetylcholine receptor antagonists
US11752149B2 (en) 2019-12-02 2023-09-12 Pipeline Therapeutics, Inc. Muscarinic acetylcholine M1 receptor antagonists
AR121846A1 (es) 2020-04-16 2022-07-13 Teijin Pharma Ltd Derivado de arilo o heteroarilo
JP7502462B2 (ja) * 2020-04-16 2024-06-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 呼吸器状態を処置するためのtrpc6阻害剤
US20250042873A1 (en) * 2021-08-24 2025-02-06 The Johns Hopkins University Compositions and methods for treating proteotoxicity-associated diseases
CN121729232A (zh) * 2023-08-18 2026-03-24 勃林格殷格翰国际有限公司 用于治疗局灶节段性肾小球硬化症的trpc6抑制剂

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040010713A (ko) * 2001-06-15 2004-01-31 야마노우치세이야쿠 가부시키가이샤 페닐피리딘 카보닐 피페라진 유도체
US7759348B2 (en) * 2003-07-30 2010-07-20 Xenon Pharmaceuticals Inc. Pyridazine derivatives and their use as therapeutic agents
CN102970965A (zh) 2010-04-05 2013-03-13 Sk化学公司 含有pde5抑制剂的减少皮肤皱纹的合成物
GB2497476B (en) * 2010-09-06 2018-01-10 Guangzhou Inst Biomed & Health Amide Compounds
WO2012037349A2 (en) * 2010-09-17 2012-03-22 Glaxosmithkline Llc Compounds
EP2556829B1 (en) * 2011-08-10 2015-08-19 Universität Leipzig Bicyclic labdane diterpenes for use in the treatment of TRPC6 associated diseases
WO2014192865A1 (ja) * 2013-05-30 2014-12-04 大日本住友製薬株式会社 フェニルピペラジン誘導体
CN103694242B (zh) * 2013-12-10 2016-01-06 昆明翔昊科技有限公司 吡唑并嘧啶类化合物及其药物组合物和其在制药中的应用
CN107253952B (zh) * 2017-08-01 2019-07-30 烟台大学 具有抗胃癌活性的trpc6抑制剂及其制备方法和用途
SG10202011632RA (en) * 2017-10-27 2021-01-28 Boehringer Ingelheim Int Pyridine carbonyl derivatives and therapeutic uses thereof as trpc6 inhibitors
CN111868055B (zh) * 2018-02-16 2024-03-08 勃林格殷格翰国际有限公司 Trpc6的抑制剂
JP7585227B2 (ja) * 2019-04-12 2024-11-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Trpc6阻害剤
JP7502462B2 (ja) * 2020-04-16 2024-06-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 呼吸器状態を処置するためのtrpc6阻害剤

Similar Documents

Publication Publication Date Title
JP2021513984A5 (https=)
JP2019518766A5 (https=)
JP2024166311A (ja) 化合物、組成物、及び、方法
JP2015501782A5 (https=)
RU2019130492A (ru) Ингибиторы интегрина avb6
JP2018531982A5 (https=)
JP2021500390A5 (https=)
JP2021508686A5 (https=)
JP2017508733A5 (https=)
JP2017502006A5 (https=)
JP2011519854A5 (https=)
JP2019519476A5 (https=)
JP2019521984A5 (https=)
JP2010528089A5 (https=)
JP2012512249A5 (https=)
JP2017522346A5 (https=)
JP2014514322A5 (https=)
JP2013522292A5 (https=)
JP2017504576A5 (https=)
JP2011513367A5 (https=)
JP2013509431A5 (https=)
JP2009534457A5 (https=)
JP2015516420A5 (https=)
JP2013525448A5 (https=)
JP2015511232A5 (https=)